Chemist & Druggist is part of the Informa Tech Division of Informa PLC


This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


This copy is for your personal, non-commercial use. Please do not redistribute without permission. Printed by #UserName#, #Company_Name#


Printed By

UsernamePublicRestriction

Well ex-CEO: We accelerated digital plans in response to Pharmacy2U

The UK’s third-largest multiple was prompted by Pharmacy2U’s “rapid growth” to “accelerate” its own digital plans, Well’s former CEO has told C+D.

While Well’s digital transformation strategy was “always part of our long-term plans”, former chief executive John Nuttall revealed that the multiple “did bring them forwards, probably as a result of competitor activity”.

Speaking to C+D in an exclusive interview in August – a month before he left the multiple to spend more time with his family – Mr Nuttall said Well noticed online-only competitor Pharmacy2U’s rate of growth was “particularly rapid, and we thought, actually, we need to accelerate our plans to look at this”.

Well began its digital transformation in 2017, with the announcement of an online repeat prescription service and a prescription delivery app. Since then it has continued its deployment of a hub-and-spoke dispensing model across its 780 branches and launched a digital subscription service called “Eddie”, for patients to order monthly supplies of Viagra Connect without having to speak to a pharmacist.

The multiple is only “part way through [its] digital transformation”, Mr Nuttall told C+D, but bringing forward Well’s plans “was the right thing to do”.

Find out how Mr Nuttall thinks pharmacy can survive the funding “doom loop” in C+D’s exclusive interview

Have you implemented any digital transformation plans in your pharmacy?

Related Content

Topics

Pre-reg Trainee

Tonbridge, Kent

 Salary: £22,000

Apply Now
UsernamePublicRestriction

Register

CD006175

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel